Biomarkers Market to Garner USD 153.34 Million and is growing with a CAGR of 14.90% Forecast by 2029, Share, Size, Trends, Applications, Investment…

Data Bridge Market Research

The increase in the prevalence of cancer across the globe acts as one of the major factors driving the growth of biomarkers market

NEW YORK, Aug. 02, 2022 (GLOBE NEWSWIRE) -- A Qualitative Research Study accomplished by Data Bridge Market research's database of 350 pages, titled "Global Biomarkers Market" with 100+ market data Tables, Pie Charts, Graphs & Figures spread through Pages and easy-to-understand detailed analysis. The statistical and numerical data are represented in graphical format for a neat understanding of facts and figures of market research analysis. Furthermore, the superior business report presents the data and information for actionable, most recent, and real-time market insights which make it easier to even take critical business decisions. The market insights gained through this Biomarkers market research analysis report facilitate a more defined understanding of the market landscape, issues that may interrupt in the future, and ways to position a definite brand excellently.

The global Biomarkers Market was valued at USD 43.13 million in 2021 and is expected to reach USD 153.34 million by 2029, registering a CAGR of 14.90% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Request to Download Sample Copy of Biomarkers Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-biomarkers-market&GNW/02Aug2022

Market Overview:-

Biomarkers are referred to as minimally or non-invasive tools. These are integrated with key imaging and data management technologies. These tools are widely utilized in imaging technology to provide clear imaging of oncology tumors and other problems. Biomarkers reduce the chance of radiation exposure during imaging through MRI scan and CT scan.

Some of the major companies which are dealing in the Biomarkers market are

Enzo Biochem Inc. (US)

Bio-Rad Laboratories, Inc. (US)

Merck KGaA (Germany)

PerkinElmer Inc. (US)

QIAGEN (Germany)

Agilent Technologies, Inc. (US)

Bruker (US)

Epigenomics AG (Germany)

MESO SCALE DIAGNOSTICS, LLC (US)

EKF Diagnostics Holdings plc (UK)

General Electric Company (US)

Nexus-Dx (US), LifeSign LLC (US)

F. Hoffmann-La Roche Ltd (Switzerland)

Story continues

Recent Development

QIAGEN N.V. (Netherlands) launched first FDA-approved tissue companion diagnostic, therascreen KRAS RGQ PCR Kit in May2021. The diagnostics will identify the KRAS G12C mutation in NSCLC tumors and expand precision medicine options.

Access Full 350 Pages Report @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-biomarkers-market?GNW/02Aug2022

Important Facts about This Market Report:-

This research report reveals this business overview, product overview, market share, demand and supply ratio, supply chain analysis, and import/export details

This research presents some parameters such as production value, marketing strategy analysis, Distributors/Traders and effect factors are also mentioned

Porter's five forces analysis, value chain analysis, SWOT analysis are some additional important parameters used for the analysis of market growth

Opportunities

Furthermore, increase in demand for personalized medicine extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Also, continuous product innovation will further expand the market.

Biomarkers Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

Prevalence of Cancer

Funds and Grants

Diagnostic Biomarker Technology

Highlights following key factors:

SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats

To View Detailed Report Analysis, Visit @ https://www.databridgemarketresearch.com/reports/global-biomarkers-market?GNW/02Aug2022

Global Biomarkers Market Scope and Market Size

The biomarkers market is segmented on the basis of type, application, product type, technology and indication. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

Application

Product Type

Consumables

Services

Software

Technology

Safety Biomarkers

Efficacy Biomarkers

Validation Biomarkers

Indication

Cancer

Cardiovascular Disorders

Neurological Disorders

Immunological Disorders

Others

Strategic Points Covered in Global Biomarkers Market Table of Content:

Chapter 1:Introduction, the basic information of the Global Biomarkers Market & product overview

Chapter 2:Objective of Study and ResearchScope of the Biomarkers Market

Chapter 3:Biomarkers Market Dynamics- driving growth factors, disruptive forces, Trends and Challenges & Opportunities

Chapter 4:Market Factor Analysis, Biomarkers Market Value Chain, PESTEL & PORTER Model, Market Entropy, Patent/Trademark Analysis

Chapter 5:Player Analysis; Competitive Landscape, Peer Group Analysis of Biomarkers Market, Strategic Group Analysis, Perpetual Mapping, BCG Matrix & Company Profiling

Chapter 6:Displaying Market Revenue Size by Type, application /vertical or end users, other Segments

Chapter 7:To evaluate the market by countries further broken down by countries

Chapter 8:Research Methodology

Chapter 9:Data Source

Explore Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-biomarkers-market&GNW/02Aug2022

Browse Trending Reports by DBMR

North America Biomarkers Market, By Type (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarker), Product (Consumables, Services, Software, Growth Hormone Therapy), Mechanism (Genetic, Epigenetic, Proteomic, Lipidomic, and Other Mechanisms), Application (Diagnostics Development, Drug Discovery and Development, Personalized Medicine, Disease Risk Assessment, Others), Disease Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Others), Country (U.S., Canada, Mexico, Germany) Industry Trends and Forecast to 2029. https://www.databridgemarketresearch.com/reports/north-america-biomarkers-market

Asia-Pacific (APAC) Biomarkers Market, By Type (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarker), Product (Consumables, Services, Software, Growth Hormone Therapy), Mechanism (Genetic, Epigenetic, Proteomic, Lipidomic, and Other Mechanisms), Application (Diagnostics Development, Drug Discovery and Development, Personalized Medicine, Disease Risk Assessment, Others), Disease Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Others), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific)-Industry Trends and Forecast to 2029 https://www.databridgemarketresearch.com/reports/asia-pacific-biomarkers-market

Europe Biomarkers Market, By Type (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarker), Product (Consumables, Services, Software, Growth Hormone Therapy), Mechanism (Genetic, Epigenetic, Proteomic, Lipidomic, and Other Mechanisms), Application (Diagnostics Development, Drug Discovery and Development, Personalized Medicine, Disease Risk Assessment, Others), Disease Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Others) https://www.databridgemarketresearch.com/reports/europe-biomarkers-market

Cancer Biomarkers Market, By Type (Genetic Biomarkers, Protein Biomarkers, Other Cancer Biomarkers) Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Blood Cancer, Melanoma, Ovarian Cancer, Liver Cancer, Stomach Cancer and Other Cancer Types), Technology (Imaging Technologies, Omic Technologies, Cytogenetic-Based Tests and Immunoassays), Applications (Drug Discovery and Development, Personalized Medicine, Diagnostics and Others), End User (Hospitals, Academic and Cancer Research Institutes, Ambulatory Surgical Centres and Diagnostic Laboratories) Industry Trends and Forecast to 2029. https://www.databridgemarketresearch.com/reports/global-cancer-biomarkers-market

North America Cancer Biomarkers Market, By Type (Genetic Biomarkers, Protein Biomarkers, Other Cancer Biomarkers), Product (PSA, HER-2, EGFR, KRAS, Others), Cancer (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Blood Cancer, Melanoma, Ovarian Cancer, Liver Cancer, Stomach Cancer, Others), Technology (Imaging Technologies, Omic Technologies, Cytogenetic-Based Tests and Immunoassays), Applications (Drug Discovery and Development, Personalized Medicine, Diagnostics and Others), End User (Hospitals, Academic and Cancer Research Institutes, Ambulatory Surgical Centers and Diagnostic Laboratories), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2029. https://www.databridgemarketresearch.com/reports/north-america-cancer-biomarkers-market

Europe Cancer Biomarkers Market, By Product (Consumables, Services, Software, Growth Hormone Therapy), Type (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers), Profiling Technologies (OMICS, Imaging Technology, Immunoassays, Cytogenetics and Bioinformatics), Service (Sample Preparation, Assay Development, Biomarkers & Testing), Application (Diagnostics Development, Drug Discovery and Development, Personalized Medicine, Disease-Risk Assessment, Others), Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Others), Country (Germany, France, U.K., Spain, Italy, Russia, Netherlands, Turkey, Belgium, Switzerland, Rest of Europe) Industry Trends and Forecast to 2027 https://www.databridgemarketresearch.com/reports/europe-cancer-biomarkers-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market ResearchUS: +1 888 387 2818UK: +44 208 089 1725Hong Kong: +852 8192 7475Email:- corporatesales@databridgemarketresearch.com

More:

Biomarkers Market to Garner USD 153.34 Million and is growing with a CAGR of 14.90% Forecast by 2029, Share, Size, Trends, Applications, Investment...

Is it trans-phobic to think female trans athletes have a leg up? – OnlySky

Reading Time: 9 minutes

I hate to admit it because it sounds so reactionary in the 21st century, but I believe some male-to-female transgender athletes, without mitigating intervention, may have an unfair advantage in womens sports.

I say this knowing that trans female athletes are a tiny minority in sports. But this is not about fear of hordes of trans competitors overwhelming womens sports. No.

This is about cisgender women being unable to secure precious entry and honors in sporting competitions because they might get beat out by someone who was born and raised with an extra quota of this hormone: testosterone.

That hormone is what, during adolescence, develops boys into adults generally bigger, stronger, and faster than females. And its a lifelong consequence.

In my view, this hormonal difference is the crux of the matter regarding trans female athletes in sports.

I know this attitude may be controversial, even reviled, by many liberals, among whom I consider myself a fellow traveler if not a card carrier, but I believe its a fair, reasonable, and defensible position.

To my mind, this is a justifiable policy conundrum, not an LGBTQ attack based on bigotry.

Of course, there are lots of people who disagree, like Jenna Scaramanga, a trans woman who recently wrote about her own feelings on this divisive topic:

[F]or some reason I care what the science says about whether trans women have competitive advantages. I really want to know the truth of it. Thats really hard, because all of the publicly-available experts seem to be either trans themselves or transphobes who do an extremely poor job of hiding their hostility. I get to spend my time reading articles and Twitter threads by people who hate me, and whoever Im reading I suspect that they are making the evidence fit a preconceived conclusion. And when I read argumentsin favorof trans womens inclusion in elite sports, I find myself worrying they arent rigorous enough. It all makes my stomach feel queasy.

I understand that for trans women, especially athletes, this is a terribly fraught issue. Lets take a look at historical data, and science to explore whether trans female athletes do get a natural, testosterone-linked sporting advantage.

Concerns about whether trans athletes enjoy baked-in competitive advantages have nothing to do with transphobia, and rather, everything to do with fairness in sports.

I fervently believe everyone has the right to proudly be whoever they inherently are, without shame, judgment, or prejudice. But if athletes have unfair advantages over their rivals, thats a problem, whether its the natural testosterone-plus benefit trans female athletes might have or other competitors doping with artificial testosterone (anabolic steroids).

Level playing fields are the heart and soul of fair athletic competition, like say a 250-pound athlete wrestling a 115-pound featherweight. Its all about fairness so that nothing untoward tips the scale of victory.

I see trans female athletes with a presumed testosterone benefit in the same vein. And while each sport is unique, a hormonal boost might have varying effects on or benefits to performanceas the International Olympic Committee acknowledged in new 2021 guidelines delegating eligibility determinations to each individual sporting body.

One could argue that if your mens team was lucky enough to have a 7-foot center, that over-endowed player would not be prohibited from playing, although a certain inherent advantage would be clearly evident. But the equalizer is that teams have a roughly equal opportunity to find naturally tall players, or three-point aces, or lazy, stumble-bum guards.

If a relatively large male-to-female trans basketball player were to suit up, eyebrows would raise about whether, due to her biology (i.e., her historical testosterone quotient), she had an unmatchable advantage.

We cant speak about this issue without addressing artificial testosterone. You might remember when China fielded Olympic teams of women swimmers in the 1990s who all looked like linebackers for the Los Angeles Raiders pro football team. In a 2012 retrospective article, the Sydney (Australia) Morning Herald wrote:

The Chinese womens swimming team came from obscurity to win 12 of 16 gold medals at the 1994 world titles in Rome, prompting suspicion among competitors, not least the Australian team.

The Chinese team was decimated by positive steroid busts at the Hiroshima Asian Games in 1994 and imploded for a second time in Perth in 1998.

At the 1994 Asian Games, the Herald wrote:

A routine customs check of a swimmers bag found enough human growth hormone to supply the entire womens swimming team for the duration of the meet.

Human growth hormone (hGH), believed to increase athletes speed, strength, and endurance, and anabolic steroids, is a synthetic form of testosterone that promotes significant muscle and strength enhancement, and has long been the illicit go-to drugs for athletes seeking to gain an advantage because even tiny improvements in physiology can bring victories. The Chinese used both.

Such substances are illegal in organized local, national, and international athletics due to the inherent and lopsided unfairness they engender in competition.

After Chinas stunning swimming dominance at 1994s World Championships, Dennis Pursley, the U.S.s national swim team director for both men and women, warned that due to very evident doping by the Chinese the future of international womens swimming could be in jeopardy without quick mitigation, according to a New York Times article that year. Pursely told the Times:

I believe you have to be incredibly naive to ignore the circumstantial evidence. The current situation is an exact replica of the G.D.R., and it is depriving deserving athletes of the attention and success they deserve.

Pursley was referring to a doping scandal at Montreals 1976 Olympics involving the German Democratic RepublicsEast Germanysathletes, particularly its swimmers. The athletes of the GDR, then a country of fewer than 17 million citizens, hauled in a trove of top medals at the games, third only to the United States and Soviet Union, whose populations then totaled hundreds of millions.

The 1976 USA Womens Olympic Team was right to cry foul, contended an article this year in Swimming World magazine. The USA team set nine American records at those Olympic Games only to see every record eclipsed by an East German swimmer riding high in the water from a systematic state-orchestrated drug program [including anabolic steroids] that claimed titles in 10 out of 11 individual races.

But the complaining Americans were portrayed by media as sore losers.

However, three years after East Germany ceased to exist with the reunification of the Federal Republic of Germany and the dismantling of the Berlin Wall in 1990, official GDR files were uncovered revealing that the GDR secret police, the Stasi, had supervised all-encompassing, systematic doping of East German athletes from 1971 to 1990. And in most cases, GRD athletes, including children, were unaware they were being doped, and state-funded labs were complicit by hiding and not reporting infractions of tested athletes.

If testosterone is relatively irrelevant to success in womens athleticsas many proponents of male-to-female trans athletes claim todaywhy were the Chinese and GDR so laser-focused on systematically doping their athletes with the substance? And why did they win so big with it?

Complicating matters, the International Olympic Committee (IOC) in 2021 released its Framework on Fairness, Inclusion and Non-discrimination on the basis of gender identity and sex variations,which delegated rule-making for trans athletes to individual sports federations, not the IOC, under a few guiding principles. Unlike previous IOC rules, testosterone levels werent among the new guidelines. The IOC wrote in a news release at that time:

Through thisFramework, the IOC seeks to promote a safe and welcoming environment for everyone involved in elite-level competition, consistent with the principles enshrined in the Olympic Charter. The Framework also acknowledges the central role that eligibility criteria play in ensuring fairness, particularly in high-level organised sport in the womens category.

The document is issued as part of the IOCs commitment to respecting human rights (as expressed in Olympic Agenda 2020+5), and as part of the action taken to foster gender equality and inclusion. In issuing this Framework, the IOC recognizes that it must be within the remit of each sport and its governing body to determine how an athlete may be at a disproportionate advantage compared with their peers, taking into consideration the nature of each sport.

Related: Life isnt fair, so why should sports be?

Of course, its noble for the IOC to prioritize the importance of inclusivity for trans people to participate equally in society, particularly in sports in this context. Indeed, Western societies are moving in tandem in this direction. But should inclusivity trump fairness?

This issue will eventually be ironed out, probably, but until more rock-solid data is gathered, it is reasonable, and fair, to try and appropriately mitigate the natural advantages trans female athletes may enjoyif they arent banned outright from competition.

Yet, prioritizing gender inclusivity or not, the overarching issue for each sport remains: how to best determine how an athlete may be at a disproportionate advantage. How can each sport now ensure competitive fairness regarding trans athletes?

With potentially huge personal and financial rewards available for successful elite athletes, this is not an idle question for athletes on the tantalizing cusp of dominance in their sports.

In her OnlySky piece, Scaramanga argues that,

The main thing you need to know about the freakout over trans women in sports is that, counterintuitively, its not about sports. FINAs spokesperson confirmed for Associated Press that there are no transgender swimmers currently competing.

But it is about sports.

As I mentioned above, the fact that relatively few transgender athletes are competing misses the fairness point. If even one trans competitor with a disproportionate advantage is victorious at the expense of a non-trans athlete, thats a travesty. As I said, its about fairness.

Deutsche Welle (DW), a German broadcast media firm, in a 2021 article said few studies have been done on elite trans athletes, but one study in 2020 of U.S. military personnel found that trans women maintain an edge after one year offeminizing hormone therapy, which usually includes suppressing testosterone levels and boosting estrogen.

Carried outby Dr. Timothy Roberts, a pediatrician and associate professor at the University of Missouri-Kansas City, and his colleagues, the researchalso found that while trans women after a year of hormone therapy continued to outperform non-transgender women, also known as cisgender women, the gap largely closedafter two years. But even then, trans women still ran 12% faster.

Still, the DW article pointed out:

Roberts, however, suggestedthe difference in running timesneeds additional perspective. It was a 12% advantage after two years in run times. But to be in the top 10% of female runners, you have to be 29% faster than the average woman. And to be an elite runner, youve got to be 59% faster than the average cis [birth-gender] woman, he told DW.

So, more concrete data is needed to show how or whether trans women athletes can fairly compete in sports, locally and internationally. Although trans female research is incomplete and results have been mixed, experts say data indicate a testosterone-boosted competitive advantage from adolescence exists, particularly in some sports, and that this edge can remain even after hormone suppression therapy such as that required by the NCAA (National Collegiate Athletic Association).

It appears some workable resolution of the conundrum may eventually be possible, either a consensus hormone-reduction protocol or, as the IOC has decided, separate sport bodies will determine their own rules concerning trans female athletes. But its not a sure thing.

An excellent article last year in the New York Times, objectively summarizes the current impasse regarding trans female athletes and concludes that any breakthrough, even if possible, likely wont be a slam dunk.

Quoted in the article is scientist Tommy Lundberg of the Karolinska Institute outside Stockholm, Sweden, who has studied this issue extensively.

It is easy to sympathize with arguments made on both sides, Lundberg told the Times regarding gender identity versus biology. But, he added, It is going to be impossible to make everyone happy.

The issue is a Gordian knot, admits Dr. Eric Vilain, a geneticist specializing in sexual development who has advised the N.C.A.A. and the International Olympic Committee on transgender athletes, and who was also quoted in the Ties article. Vilain says the reason for this is that sports leaders face two almost irreconcilable positions in setting eligibility standardsone relying on an athletes declared gender and the other on biological litmus tests.

So the research and hand-wringing continues.

At the moment, though, sports bodies seem to be taking a cautionary approach. As Scaramanga wrote in her essay, FINA, the international swimming federation, has, pending further research into the issue, banned trans women from competing in womens categories for all the sports it governs, and 18 American states now ban trans teens from competing in school sports.

Sixteen athletes on female trans competitor Lia Thomas University of Pennsylvanias swim team sent a letter to the school and Ivy Leagueofficials stating that they believed Thomas competing on the team was unfair to other teammates. On the other hand, 23 teammates support Thomas.

We fully support Lia Thomas in her decision to affirm her gender identity and to transition from a man to a woman. Lia has every right to live her life authentically, the letter from opposing teammates states, per theWashington Post. However, we also recognize that when it comes to sports competition, that the biology of sex is a separate issue from someones gender identity.

The concerned teammates noted that when Thomas competed as a collegiate male, he was then ranked 462nd, while as a female she ranked No. 1.

These are fair concerns of athletes who focus all their prodigious energy on excelling in their sports and, as steroid-pumped Chinese and East German athletes once powerfully demonstrated, the hormones in our bodies naturallyor unnaturallycan unfairly tip the balance of victory. Or, on the flip side, deny the rewards of excellence.

This issue will eventually be ironed out in some fashion, probably, but until more rock-solid data is gathered, it is reasonable, and fair, to try and appropriately mitigate the natural advantages trans female athletes may enjoyif they arent banned outright from competition.

The end goal is to not inadvertently disadvantage cis-gender female athletes as gender fluidity becomes more a front-and-center issue in Western societies and increasing efforts are made to include trans athletes in sports.

The goal is to ensure fairness for all athletes.

Related Posts

Original post:

Is it trans-phobic to think female trans athletes have a leg up? - OnlySky

You can get a workout ‘hangover’ if your exercise routine is too intense – The Star Online

Certain sensations can set in after a workout, such as headaches, nausea or dizziness symptoms comparable to those of a hangover.

But some good habits to get into before and after exercising can help you avoid these discomforts.

We all know that regular exercise is one of the keys to staying healthy.

And the benefits of sport are numerous working out improves blood circulation, helps you lose body fat, maintains your joints and bones, reduces stress and the risk of cancer, etc.

But after a session thats too intense, some symptoms resembling those of a hangover can set in, such as exhaustion, nausea and headaches.

According to a survey conducted in the United States in May 2019, nearly one in four Americans have experienced this, to the point of being unable to do another activity or get to work.

One reason behind this effect may lie in hormones.

To stimulate muscle and tissue growth, the body produces growth hormone.

After too much effort, this production may get too high, leading to nausea.

Dehydration is also a possible cause.

Not drinking enough water can lead to migraines, dizziness and muscle cramps.

Finally, exercise that is too intense can temporarily weaken the immune system, making it less able to defend the body against viruses.

To limit these symptoms, it is advisable to pay attention to your diet, eating between one and three hours before your workout, so that the body has the necessary fuel to draw on its reserves.

Thorough warm-up and cool-down stretching sessions are also recommended, as is regular hydration to help the muscles recover. AFP Relaxnews

Excerpt from:

You can get a workout 'hangover' if your exercise routine is too intense - The Star Online

A Nutritionist Tells Us Exactly What To Eat For The 10-Day No Carbs, No Sugar Challenge (JLo Swears By It!) – SheFinds

And just like that, were more than halfway through 2022. Time flies! At one point, youve probably had a mini existential crisis already and chances are youve revisited some of your New Years resolutions. As a matter of fact, the status of your overall health might be one of those things thats been running in your mind. If you feel like youve lost track of your weight loss goals, we got you covered. Theres one diet that you might want to try. (Hint: Its J-Lo approved!)

Introducing, the 10-Day No Carbs, No Sugar Challenge. Check it out below.

As the name simply suggests, this diet restricts you from eating carbs and sugar. But is it actually effective for weight loss? And what exactly do you eat throughout this challenge? We asked Dr. Amy Lee, board certified doctor in internal medicine, medical nutrition and obesity medicine and partner ofNucific to find out. Keep reading for more.

According to Dr. Lee, There are many dietary regimens out there now that have various claims, but from my experience in nutrition science, cutting out simple or processed sugars and carbs from ones diet is one of the best ways to lose weight.

She explains, Simple sugars and carbs trigger the body into secreting insulinwhich is a growth hormone. If you put your body into that state where you are constantly secreting insulin, you may end up telling your body to storesugar into fat storage. Dr. Lee warns, Before you know it, the body may become less efficient in secreting insulin or your organs/muscles become less sensitive to the action of insulin, which then results in what we call diabetes. Along with storage, there is weight gain.

She notes, The best thing to do in ones diet is to watch out for things that trigger secretion of insulin spikes and focus on foods that dont do that to the body.

For those who would like to follow this diet, [you should eat] lean proteins (animal or vegetarian sources), fruits and vegetables, good fats from nut butters, [and] fish oils. These are items that have less impact on the way the body secretes insulin, Dr. Lee tells us.

Dr. Lee confirms, Yes, absolutely. Once you learn to cut out sugars and simple carbs, your body will find ways to look for fuel, and one way is metabolizing your fat storage (fat burn for fuel). [This does] not only help with shrinking down fat cells and causing weight loss, but also [decreases] inflammation. What a win!

Excerpt from:

A Nutritionist Tells Us Exactly What To Eat For The 10-Day No Carbs, No Sugar Challenge (JLo Swears By It!) - SheFinds

Pig to human heart transplants are the future. Are we ready for it? – The Guardian

Shards of electricity burned through Mr Ps flesh. Layers upon layers of subcutaneous fat unraveled, filling the operating room with a pungent, metallic odor, like singed hair at the neighborhood barbecue. Within a few minutes, the pearly white bone of the sternum stuck out before a vein split open, filling the operative field with blood.

Zap! Maroon juice turned into a crackly black mass.

Transplant surgery is all about timing, says Dr Brandon Guenthart, a cardiothoracic surgeon at Stanford University School of Medicine. Anesthesiologists put the patient to sleep after the retrieval team confirms the donor heart looks good. Two surgeons start operating an hour before the donor heart arrives in the hospital. They dont begin cutting the patients heart out until the donor heart has landed safely at the local airport.

And if the plane crashes? Knock on wood, says Guenthart. Theres unfortunately no wood in the operating room.

I was at Stanford hospital watching this heart transplant because of my interest in David Bennett, a 57-year-old man who had died back in March. On 7 January 2022, at the University of Maryland Medical Center, Bennett had received a landmark heart transplant from an unusual donor: a genetically modified pig.

In 2021, a record 41,354 human-to-human organ transplants were performed, but over 100,000 Americans are still stuck on the transplant list. Every day, 17 people die waiting because there simply arent enough organs to go around.

Xenotransplantation or transferring cells, tissues and organs between species promises to solve this shortage and to reshape how we think about human longevity.

Lost in this boundless potential, however, is the significance of the human-animal divide. People walking around with pig organs melded into their bodies human-animal cyborgs of sorts can seem dystopian. And with the zoonotic Sars-CoV-2 virus having killed more than 6 million people, violating the interface between humans and animals may just promise more catastrophe.

This tortuous relationship is nothing new, but its often sanitized and hidden from sight think grinning cows on milk cartons and secret bunkers for animal research. Left open is a whole host of questions, starting with the most complex of all: what does it mean to be human?

Humans are animals. But animals are not humans. And yet, our history is rife with a cultural imagination of hybridity. The ancient Egyptian god of the sky, Horus, was depicted with a falcon head and the goddess of war, Sekhmet, that of a lioness. Similarly, the Hindu god Ganesha was beheaded and then resurrected with an elephant head grafted on to his body. In ancient Greece, fantastical creatures roamed the myths, from the bull-headed Minotaur to the snake-haired Medusa.

Within this wealth of options, the International Xenotransplantation Association chose a more obscure mascot: the Lamassu, an Assyrian deity with the body of a bull, the wings of a bird, and the head of a man a grounding wisdom.

Xenotransplantation, as a research field, started only with cells and tissues. In 17th-century France and England, blood was transfused from animals to humans to cure a whole host of medical conditions. Spiritual meaning was imbued into the act: Since Christ is the lamb of God, one recipient wrote in a letter to the Royal Society, sheeps blood possess[es] a symbolic relationship with [his] blood. One patients violent fever was purportedly cured, as was another patients paralysis, but at least two others died soon after these xenotransfusions.

Other early xenotransplants would follow, including ones with the bone, cornea and skin. Perhaps most infamously, the French surgeon Serge Voronoff transplanted slices of chimpanzee and baboon testicles into men, and ape ovaries into women, to rejuvenate his patients zest for life. Thousands of these operations were performed around the world, but any reported benefit, such as reduced fatigue or increased sex drive, was probably only the placebo effect and quickly faded.

While cell and tissue xenotransplants have been performed for centuries, whole organ transplants were more difficult to figure out. Sewing all the blood vessels together is a tricky business. You have to put two floppy tubes together mouth-to-mouth, tying them tight enough that the patient doesnt bleed out, but delicately enough that the patient doesnt have major clotting either.

This was a Nobel prize-level problem that the French surgeon Alexis Carrel solved with a small embroidery needle and fine silk suture, and was recognized for in 1912. Hes sometimes known as the father of transplant surgery.

A half-century later in 1964, the University of Mississippi surgeon James Hardy attempted the worlds first cardiac transplant, transferring Bino the chimpanzees heart into the chest of the rapidly deteriorating 68-year-old Boyd Rush. Rush survived for only 90 minutes, with the chimp heart offering insufficient support and rejection quickly shutting down his body.

It was Baby Fae who truly set the stakes for xenotransplantation. She was a 12-day-old infant with hypoplastic left heart syndrome, a congenital abnormality where the left side of the heart is a sliver of its full form. The condition was a death sentence.

So, in 1984, surgeons at Loma Linda University, California, transplanted a walnut-sized baboon heart into Baby Faes chest. The conditions were almost perfect. The heart was well-sized, Baby Faes immune system was immature (and sympathetic), and the immunosuppressive drug cyclosporine could suppress attacks on the baboon heart.

After the operation, Baby Fae seemed to be doing well. Resting in her crib with a gauze-covered scar traversing her chest, she was just gulping down her formula and wailing with a lusty cry, according to the hospital spokeswoman. The hospital also released photos of Baby Fae talking with her mother, the phone receiver bigger than her entire torso.

She died 21 days after her operation, her immune system refusing to accept the new infant-baboon hybrid. Outrage from physicians and the public soon followed, with animal-rights activists protesting and bioethicists publishing articles like Baby Fae: The Anything Goes School of Human Experimentation.

Xenotransplantation died with Baby Fae, if only for a little while.

During surgery when the drapes are on, its not really a person, Guenthart said. Its a task.

Technically speaking, a heart transplant is pretty easy. It takes only five incisions to cut out the failing heart, and only five connections to put in the new one. Electrocautery in one hand, scissors in the other, you usually first cut out the superior vena cava the vessel bringing back blood to the heart from the head, neck, arms and chest because its the most accessible structure.

Next is the inferior vena cava, which brings back blood from down south but is a bit hard to reach. So, you cut off a portion of the hearts right chamber where this vessel drains into.

Then comes the aorta and pulmonary arteries in fairly simple, straightforward incisions. More difficult are the pulmonary veins, because these are four delicate vessels that are almost impossible to reconnect. The way around that is to lift the heart up and cut out a rim of left heart tissue from underneath. You create a swimming pool, or a little crater, Guenthart said. He paused. Thats just me giving a description. They dont actually call it a swimming pool.

Regardless of whether youre transplanting a human heart or pig heart into someone, the steps are essentially the same.

If you asked 99 doctors out of 100, they wouldnt be able to tell you if they were looking at a human chest or pig chest, Guenthart said.

Pigs are filthy animals, as conventional wisdom goes. Judaism and Islam prohibit consumption of pork and other unclean meat. The insult cops are pigs bears undeniable teeth. And in the Odyssey, the sorceress Circe transforms Odysseuss gluttonous men into swine.

Pigs are also highly intelligent animals, capable of showing emotions. Some 11,000 years ago, wild pigs may have domesticated themselves, recognizing a benefit to allyship with humans. They like playing fetch, are whizzes at navigating mazes, and can outsmart dogs and chimpanzees, according to their IQ tests.

Following the Baby Fae experiment, primates fell out of favor for xenotransplantation, and pigs became the new model organism for researchers to develop.

If you ask xenotransplantation experts today, theyll give a laundry list of reasons why pigs are better than baboons: they are more easily genetically manipulated, they can be raised in a sterile environment to reduce infections, and they can be grown to give organs of any size needed.

Its a nice packaged narrative, but Dr Brad Bolman, historian of science at the University of Chicago, argues that sheep, goats or some other animal could have been deemed suitable instead. At the outset, Bolman said, it wasnt obvious that pigs were the right replacement for non-human primates. But when pigs were chosen, the scientific ideals were constructed retroactively to make them seem like the clear choice all along.

Bolman says that pigs were chosen because it was socially and economically convenient. They produce large litters quickly, with piglets reaching adult human size in six months. Theres also an almost unlimited supply of them 700 million worldwide and as agricultural animals, they arent covered by the Animal Welfare Act.

We treat pigs in ways that we would never treat people, but we also recognize theyre so similar to us that theyre our models, said Dr Lisa Moses, a bioethicist and veterinarian at Harvard Medical School. You cant make sense of that because it doesnt make sense. Its one giant paradox. Pigs are close enough to give their lives for ours but not close enough that their plight gives us pause.

Maybe it should. If you subscribe to Kantian ethics, its wrong to use others as a means to an end, so it feels downright exploitative to genetically modify a pig and kill it for its heart. People for the Ethical Treatment of Animals (Peta) has thus decried pig-to-human transplants as unethical, dangerous, and a tremendous waste of resources, asserting that animals arent toolsheds to be raided but complex, intelligent beings. Kathy Guillermo, a senior vice-president at Peta, went even further to proclaim, pigs are people.

These ethical concerns arent new. In 1999, the Campaign for Responsible Transplantation protested in New York Citys famous Halloween Parade, with members dressed up as genetically engineered monsters. As millions of Americans watched the parade on TV, these snout-wearing attendants hoisted a 13ft-tall mad scientist puppet, sporting a dollar sign tie and clenching a pig-human hybrid.

But the xenotransplantation experts I spoke to often dismissed these ethical concerns by citing the structural fact of the global pork industry. The thinking goes that, if pigs are going to be eaten anyway, they might as well be used for science, a more valuable and noble pursuit.

If you think about eating in a slightly more capacious sense, Bolman said, eating is really about consumption and rendering animals destroyable. More than anything else, the edibility of pigs justifies their usage for xenotransplantation and research at large.

What science does is consume animals, even if they arent literally eaten, said Bolman. Science remains carnivorous.

Mr Ps new heart had arrived in the operating room a half-hour ago, and Guenthart was zigging and zagging a fine thread across the arc of two vessels to cinch them together.

Six oclock, seven oclock, eight oclock Guenthart stitched together one half of the artery before he grabbed another needle to run around counterclockwise. Once the two sutures had circled around and met at noon, he threw a right-handed knot, and then another. Then left-right-left-right-left-right, each opposing throw locking the last one into a square knot, Guentharts hands dancing with the fine thread.

During the entire operation, everyone in the operating room was chatting away, but now it was so silent you could hear the faint music that had been playing all along. This was the crucial moment where, with the donor heart actively dying, Guenthart was sewing as fast as he could to restore blood flow to the heart. Every second counted.

Clamp off, Guenthart finally announced. With the pressure released off the aorta, blood rushed into the coronary arteries and fed the heart.

Having graduated from medical school a decade ago, Guenhart joked that xenotransplant is the promise thats 10 years out and always will be. But he also sees Bennetts 60-day survival as an amazing milestone and xenotransplantation as the most promising solution for the organ shortage killing his patients.

After about 30 seconds, Mr Ps new heart started beating on its own, like a zombie rising from the dead. Guenthart hadnt connected any of the nerves and definitely nothing to his brain. The hearts internal pacemaker is the circus master of its own show.

Xenotransplantation requires selective humanization of a pig. If you transplant a pig heart into a human, just like that, it will get rejected. Specifically, itll turn an ugly black and be flooded with blood clots, according to Dr Richard Pierson, director of the Center for Transplantation Sciences at Massachusetts general hospital. (I spoke with Pierson as he was speeding down to the hospital for a human-to-human lung transplant, ambulance sirens hollering in the background.)

Because our immune police force is so good at its job, the Virginia-based biotech company Revivicor used the gene-editing technology Crispr to create a special line of pigs with 10 modifications. Four genes are knocked out, and six genes are added in.

So, what is the recipe for making a pig heart fit for humans?

1. Knock out three sugar genes that are only found in pigs. Most of us think if you have a pig with those three genes knocked out, thats probably better than just one. We dont know that for sure, Pierson said.

2. Knock out a growth hormone gene to prevent the pig heart from overgrowing its new home. Pierson said, Is growth at the graft going to be a problem? We dont know.

3. Add two complement inhibitor genes that prevent antibodies from destroying the pig heart and two anti-clotting genes that stop the patients blood from curdling inside the foreign organ.

4. Add two anti-inflammatory genes to prevent the pig heart from swelling up. One of these genes signals to the immune system that the pig heart is a friend (self), not food (nonself). That may or may not be necessary, said Pierson. It probably is helpful, but we havent proven that.

After all this cutting and pasting, the next challenge is to keep the pig clean. The last thing you want is to transplant a pig heart with viruses, bacteria and parasites that cause infections in humans.

Therefore, these pigs are raised in pathogen-free facilities. There are no windows. They dont go outside. The air is filtered and sterilized, said Dr Leo Buhler, editor-in-chief of the journal Xenotransplantation and professor of surgery at the University of Fribourg.

After the genetically engineered embryos are implanted, the surrogate sows have to undergo caesarian sections (a vaginal birth is more likely to cause an infection.) The piglets are then immediately taken to isolation boxes under infrared lights, allowed to suckle their mother only every two hours under scientist supervision.

After 24 hours, the sows are all removed from the facility, and the piglets are artificially fed with a motherless rearing system and formula. Any interaction with humans must happen with the highest level of personal protective equipment.

With this pig-in-a-bubble approach, you should get a line of pigs that has never had any contact with the outside world and whose exogenous, or external, viruses have all been eliminated. These pig hearts are safe to implant into humans then, right?

Not exactly. Bennetts heart still tested positive for pig endogenous retroviruses (PERV) viruses built into the porcine genome that can jump into human cells, at least in a Petri dish. Its an alarming example of zoonosis that could lead to a pandemic like Covid-19.

Whether or not those viruses can infect humans remains to be seen, but Pierson doesnt think it will be a major barrier to xenotransplantation. HIV drugs seem to be relatively effective against them, and Boston-based biotech company eGenesis has already made a 60-gene PERV-free pig.

So what does worry Pierson about xenotransplantation?

The unknown unknown, he said. You can run a battery of tests in search of viruses, but you might only find what youre looking for. And with a cocktail of immunosuppressants required to sedate our trigger-happy immune system, any infection that crosses the pig-human barrier could wreak devastating consequences.

Doesnt this all feel a bit premature, then? I ask Pierson.

Worry is not a reason not to do things. You need to take cautious steps forward. If the problem presents itself, you figure out a way to solve it. You dont just go home.

For months, Bennetts transplant had been shrouded in secrecy, but the details of the operation were finally unveiled in a mid-June report of the New England Journal of Medicine. One of the studys blockbuster findings was that Bennett was infected with a pig virus. The paper itself is neutral on the cause of death, but the cardiothoracic surgeon and study first-author Dr Bartley Griffith is slightly betting that a pig virus killed Bennett.

The pig virus hes referring to is not a PERV, however; its an external virus called porcine cytomegalovirus (pCMV).

pCMV is a member of the herpes family, and its human form is known for causing mononucleosis, the kissing disease. Dont let that fool you though. Cytomegalovirus causes inflammation and damage to the organ, Pierson told me. A lot of damage.

pCMV is also one of the viruses that Revivicor had supposedly eliminated from pigs through all their precautions; it has been a well-recognized threat to xenotransplantation for decades.

When it first showed up, we thought maybe it was just an error or something, Griffith said, discussing how a routine blood draw on the 20th day after surgery returned a tiny blip.

Possible pCMV infection was so unimaginable to Griffiths team that they werent even looking for this pig virus and discovered the infection only on accident. Griffith told me, The first thing we did is we went to the company and said, How can we possibly be seeing this?

One xenotransplantation expert who wished to remain anonymous for legal reasons thinks that Revivicor may have gotten a bit slack about their protocol. He says the evidence is clear that, with early weaning and all other precautions, pigs dont get pCMV.

Revivicor, of course, tested the donor pig several times with a nasal swab and PCR, getting negative results every single time. It looks like PCR is not sufficient to exclude silent pCMV that can reactivate in an immunosuppressed environment, Buhler wrote to me. He suggests that Revivicor made an honest mistake by not using a more specific test. (Revivicor did not respond to repeated queries sent by the Guardian.)

Regardless of why pCMV was missed, the results were gruesome on autopsy. After hitchhiking into Bennett, the virus seems to have exploded some capillaries and killed the heart.

But Griffith is continuing to march along, hoping to do another xenotransplant in the next few months, even if he isnt entirely sure yet why Bennett died. Whatever it was, hes confident that it can be overcome. A pCMV infection? Exclude it. Too much immunosuppression? Reduce it. The anti-pig antibodies they gave Bennett? Dont do that again.

Thats how you make progress, Griffith said. You admit where you made errors, and you try to limit them. But you move on.

In a world where we are humanizing pigs with Crispr and piggifying humans with xenotransplantation, what does it even mean for there to be a human-animal divide?

In some ways, the word divide is problematic. After all, theres no bright red line separating humans from other animals. Pigs and humans share 98% of genes, and that 2% is critically important. But its also just 2%.

Moses, the Harvard bioethicist, believes that the notion of a human-animal divide is an artificial construct. Theres been a concerted effort from the biomedical research community to enhance the perception of that divide, going back as far as Descartes and Francis Bacon, she said.

Built on a shaky foundation, the separation between animals and humans has been reified over millennia. Look no further than the impossibly low sticker prices of a pack of bacon that hides environmental externalities and inhumane conditions under a crisp cellophane wrap. Its easier to not think too hard about it.

But we cant not think hard about xenotransplantation. If its promise is to be realized, well have to, at the very least, create a whole new economy of factory farming, where pigs will be manufactured and slaughtered en masse to give us life.

Sure, 1.5 billion pigs are already killed each year. And sure, if the people you loved most had heart failure, lungs slowly drowning in fluid, their dilated heart twisting agonizingly, youd probably take the pig heart instead of gambling with the transplant list. I would, at least. But that shouldnt obviate the need to tread carefully here.

Dr Chris Walzer, executive director of the Wildlife Conservation Society, thinks xenotransplantation could benefit from the OneHealth framework the idea that human, animal and environmental health are all connected.

Take the Nipah virus as an example. Nipah is a zoonotic disease that has caused deadly outbreaks in Malaysia, Singapore, Bangladesh and India. For years, these outbreaks were a mystery to epidemiologists, who couldnt understand how the transmission chain worked between fruit bats the natural hosts of the virus and humans. And ultimately, it took a broadened perspective to solve this puzzle tracing how date palm trees bloomed in the winter, how fruit bats infused tree sap with saliva and urine, and how humans consumed that infected sap and got Nipah.

Its too simple to say pigs are people. And its too simple to say pigs are an unlimited supply of organs. Seventeen people die every day waiting on the transplant list, but xenotransplantation is about a whole lot more than just saving these lives.

Were all part of a shared ecology. And theres a danger to ignoring our interconnectedness.

Earlier that day, Guenthart had told Mr P that he was getting a new heart. Mr P started crying. Hes in his early 20s, and three months ago, his heart started failing without any apparent reason. His doctors still arent sure why.

It was hard for me to not also start crying, Guenthart said.

A heart transplant is a highly technical operation, but for the patient, its a chance at life. When David Bennett had his xenotransplant, he didnt just get a pig heart; he got two more months of life. He watched the Los Angeles Rams win the Super Bowl. He sang America the Beautiful with his therapist. He spent time with his five grandchildren, every day begging his surgeons to let him go home to his dog Lucky.

Now that the transplant was over, Guenthart was calling Mr Ps mom.

The surgery went really well. The new heart looks beautiful, and hes doing amazing. Hes asleep right now, and were sending him over to sleep in the ICU.

Yes, hes going to be two floors above where he was before.

Normal visiting hours are from 8am to 7pm, but you can call them at any time and get updates directly from his nurse.

Of course, youre so welcome, and I hope to see you tomorrow.

Read more:

Pig to human heart transplants are the future. Are we ready for it? - The Guardian

Global Endocrine Testing Products Market Size Is Expected To Grow At A CAGR Of Approx. 10% From 2022 To 2032 – Digital Journal

Evolve Business Intelligence published a new market research report on Global Endocrine Testing Products Market by Product Type (Instruments/Analyzers and Consumables), by Technology (Liquid Chromatography-Mass Spectrometry, Immunoassay, Monoclonal and Polyclonal Antibody, Electrochemical/Biosensor (Sensor), and Clinical Chemistry), by Test Type (Adrenocorticotropic Hormone (ACTH), Calcitonin, Calcium, Cortisol, Catecholamine, Dehydroepiandrosterone Sulfate (DHEA-S), Estradiol, Follicle Stimulating Hormone, Growth Hormone, Luteinizing Hormone, Prolactin, Progesterone, Testosterone, Thyroid Stimulating Hormone, Vitamin D, and Others), by Disease Indication (Adrenal Insufficiency and Addison Disease, Bone Disorders, Cancer (Tumor), Infertility, Renal Diseases, Metabolic (Including Diabetes) and Gastrointestinal Disorders, Pituitary Disorders, Thyroid Disease, and Others), by End User (Hospitals & Clinics, Diagnostic Laboratories, Satellite Laboratories, Commercial Labs, Home Care Settings, and Ambulatory Care Centers) and By Geography COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends, and Forecast from 2022 to 2032

The global endocrine testing products market Size Is Expected To Grow At A CAGR Of Approx. 10% From 2022 To 2032. The Endocrine Testing Products Market report provides data on industry size and growth rate, globally and by region. It includes market drivers, challenges and opportunities. This data allows the business to assess market capability of the industry, understand current trends including the growth rate of this particular field as per the data provided in this report for thorough insight into what will happen in future for that particular field as per the data provided in this report from a local or global perspective. The Report can help provide an advantage force on both scale.

Request Free Sample Report or PDF Copy: https://report.evolvebi.com/index.php/sample/request?referer=parity&reportCode=015397

Key PlayersThe Endocrine Testing Products market report gives detailed information about the company and its past performance. This will give you a clear picture of how strong an industry is, what kind of wealth is involved with it, and which fields are growing over time. Each and every element within a market report are updated regularly so that we can read the market better. The report also includes common risks associated with marketing in such a delicate industry as they present advice for future planning for business expansion accordingly.

The key players profiled in the report are: F. Hoffmann-la Roche Ag Abbott Laboratories Agilent Technologies BioMerieux S.A. Bio-Rad Laboratories, Inc. Siemens Healthineers Danaher Corporation DiaSorin S.p.A. Immunodiagnostic Systems Laboratory Corporation of America Holdings (LabCorp) Fujirebio, Inc. Thermo Fisher Scientific Inc. Quest Diagnostics Sysmex Corporation MP Biomedicals Ortho Clinical Diagnostics Meridian Life Science, Inc.

Todays business environment is competitive and challenging, which means businesses need to be on top of new technologies and seek out market opportunities. Our recent research on the global Endocrine Testing Products industry sheds light on the current state of the industry, including market size, key players, and SWOT analysis. The analysis serves as part of our qualitative assessment: we factored in findings from our own study to help readers decipher what they can do to embrace opportunity or prevent threats that may hinder the market moving forward.

COVID ImpactIn terms of COVID 19 impact, the Endocrine Testing Products market report also includes the following data points: COVID19 Impact on Endocrine Testing Products market size End-User/Industry/Application Trend, and Preferences Government Policies/Regulatory Framework Key Players Strategy to Tackle Negative Impact/Post-COVID Strategies Opportunity in the Endocrine Testing Products market

For Inquiry or Customization: https://report.evolvebi.com/index.php/sample/request?referer=parity&reportCode=015397

Scope of the Report:Market Segment By Product Type with focus on market share, consumption trend, and growth rate of Endocrine Testing Products Market: Instruments/Analyzers Consumables

Market Segment By Technology with the focus on market share, consumption trend, and growth rate of Endocrine Testing Products Market: Liquid Chromatography-Mass Spectrometry Immunoassay Monoclonal and Polyclonal Antibody Electrochemical/Biosensor (Sensor) Clinical Chemistry

Market Segment By Test Type with the focus on market share, consumption trend, and growth rate of Endocrine Testing Products Market: Adrenocorticotropic Hormone (ACTH) Calcitonin Calcium Cortisol Catecholamine Dehydroepiandrosterone Sulfate (DHEA-S) Estradiol Follicle Stimulating Hormone Growth Hormone Luteinizing Hormone Prolactin Progesterone Testosterone Thyroid Stimulating Hormone Vitamin D Others

Market Segment By Disease Indication with the focus on market share, consumption trend, and growth rate of Endocrine Testing Products Market: Adrenal Insufficiency and Addison Disease Bone Disorders Cancer (Tumor) Infertility Renal Diseases Metabolic (Including Diabetes) and Gastrointestinal Disorders Pituitary Disorders Thyroid Disease Others

Market Segment By End User with the focus on market share, consumption trend, and growth rate of Endocrine Testing Products Market: Hospitals & Clinics Diagnostic Laboratories Satellite Laboratories Commercial Labs Home Care Settings Ambulatory Care Centers

For more information: https://report.evolvebi.com/index.php/sample/request?referer=parity&reportCode=015397

Key Region/ Countries Covered North America (US, Canada, Mexico) Europe (Germany, U.K., France, Italy, Russia, Rest of Europe) Asia-Pacific (China, India, Japan, South Korea, Rest of Asia Pacific) Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of MEA) Latin America (Mexico, Brazil, Argentina, Rest of Latin America

Asia Pacific is projected to grow at the highest Compound Annual Growth Rate (CAGR) during the forecast period.Reasons to Buy this Report: Get detail analysis of the impact of market forces on your products & Services Competitive Intelligence providing the understanding about the ecosystem and its need Details analysis of Total Addressable Market (TAM) of your products Investment Pockets and New Business Opportunities Strategy Planning The Endocrine Testing Products market report provides historical data and revenue forecasts for the different regions, which includes North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa

About EvolveBIEvolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging the pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from fortunes global 2000 companies.Contact Us:Evolve Business IntelligenceIndiaContact: +1 773 644 5507 (US) / +441163182335 (UK)Email: [emailprotected]Website: http://www.evolvebi.com

Go here to read the rest:

Global Endocrine Testing Products Market Size Is Expected To Grow At A CAGR Of Approx. 10% From 2022 To 2032 - Digital Journal

‘Dont sabotage’ gains with poor nutrition – the ‘right’ foods to eat for results – Express

Skinless chicken

Chicken has long been favoured by athletes and features in many weight loss diets.

This is because it is an excellent source of high-quality protein, which is important for muscle maintenance and repair, bone health and weight management.

Cottage cheese is a good source of vitamin B12, calcium and other important nutrients, but it is also packed full of one very important micronutrient too.

Not many people know this but cottage cheese is almost entirely pure casein protein," Wayne revealed.

Casein is a slow-digesting protein, meaning it is perfect for muscle maintenance.

"This is useful especially for people who have no choice but to go long periods without eating," he added, as it's high in satiety.

Eggs contain high-quality protein, nine essential amino acids, choline, the right kind of fat, and vitamin D.

Whole grains digest more efficiently and provide more nutrients than refined grains, promoting sustained energy levels and overall health.

Bown rice especially can help boost growth hormone levels, which are "critical" for encouraging lean muscle growth, fat loss, and strength gains.

Read more here:

'Dont sabotage' gains with poor nutrition - the 'right' foods to eat for results - Express

Infrared Search And Track (IRST) System Market Size to Grow by USD 879.44 million, ASELSAN AS and HGH Systemes Infrarouges SAS Among Key Vendors -…

Get a comprehensive report summary describing the market size and forecast along with research methodology. The FREE sample reportis available in PDF format

Infrared Search and Track (IRST) System Market 2022-2026: Scope

Theinfrared search and track (IRST) system marketreport covers the following areas:

Infrared Search and Track (IRST) System Market 2022-2026: Vendor Analysis

ASELSAN AS, Excelitas Technologies Corp., HGH Systemes Infrarouges SAS, Leonardo Spa, Lockheed Martin Corp., Northrop Grumman Corp., Raytheon Technologies Corp., Rheinmetall AG, Safran SA, Thales Group, and Tonbo Imaging India Pvt Ltd. are among some of the major market participants. The key offerings of some of these vendors are listed below:

This report provides a full list of key vendors, their strategies, and the latest developments. Request a FREE PDF Sample Now

Infrared Search and Track (IRST) System Market 2022-2026: Segmentation

Infrared Search and Track (IRST) System Market 2022-2026: Key Highlights

Related Reports

Infrared Aerial Camera Marketby Application and Geography - Forecast and Analysis 2021-2025

Shortwave Infrared Marketby Product and Geography - Forecast and Analysis 2022-2026

Infrared Search And Track (IRST) System Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 3.15%

Market growth 2022-2026

USD 879.44 million

Market structure

Fragmented

YoY growth (%)

2.33

Regional analysis

North America, Europe, APAC, South America, and Middle East and Africa

Performing market contribution

North America at 38%

Key consumer countries

US, China, France, Germany, and UK

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

ASELSAN AS, Excelitas Technologies Corp., HGH Systemes Infrarouges SAS, Leonardo Spa, Lockheed Martin Corp., Northrop Grumman Corp., Raytheon Technologies Corp., Rheinmetall AG, Safran SA, Thales Group, and Tonbo Imaging India Pvt Ltd.

Market Dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse Information Technology MarketResearch Reports

Table of Contents:

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Five Forces Analysis

5 Market Segmentation by End-user

6 Customer Landscape

7 Geographic Landscape

8 Drivers, Challenges, and Trends

9 Vendor Landscape

10 Vendor Analysis

11 Appendix

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio ResearchJesse MaidaMedia & Marketing ExecutiveUS: +1 844 364 1100UK: +44 203 893 3200Email: [emailprotected]Website: http://www.technavio.com/

SOURCE Technavio

See the original post here:

Infrared Search And Track (IRST) System Market Size to Grow by USD 879.44 million, ASELSAN AS and HGH Systemes Infrarouges SAS Among Key Vendors -...

Somatropin Market Increasing focused on developing advanced of growth hormone deficiency is expected to boost the growth of the market – Digital…

The global Somatropin market was valued at $ 5.02 Bn in 2019 and is forecast to reach a value of $ 8.56 Bn by 2027 at a CAGR of 7.9% between 2020 and 2027.

SomatropinMarket report 2022 provides detailed study of market concentration rate of raw materials, sales, revenue, price trend by type, competitive landscape. The Somatropinmarket report includes historical and forecast data, manufacturing process analysis, demand, industry share, market size by volume and value, applications, types and geography.

Leading suppliers are working on offering high-quality, cost-effective, and new technologies using current materials to get a competitive advantage in the market. Leading manufacturers are competing in cost, quality, design, and aftermarket service. With technological skills and investments through partnerships and contracts, the competition is growing and improving.

Receive A Full PDF Sample Copy Of Report:( Including Full TOC, List of Tables & Figures, Chart) @https://www.coherentmarketinsights.com/insight/request-pdf/4062

Large corporations must have a thorough awareness of market characteristics, such as important inventions, market techniques, pressure and constraint variables, and price trends, in order to make critical business decisions and produce massive profits. ThisSomatropinmarket reports market size data in these key sectors will aid essential organisations in making the proper investments and launching items to market. Key players, vendors, and manufacturers can utilise this in-depth market research to obtain a better knowledge of the elements that drive business growth. Competitive considerations, advancement rates, industry trends, significant company profiles, and business expansion elements are just a few of the themes covered here.

Major Key players in this Market:

The Following are some of the key questions addeessed in the report:

To obtain crucial data such as market size, trends, and income examination, approved basic and optionalSomatropinresearch approaches and information sources are proposed.Cutthroat industry circumstance, gross edge investigation, value designs, and growth possibilities are all recognised as keySomatropinbits of knowledge.This research provides a detailed analysis of globalSomatropinmarket patterns, value, creation, and advertising techniques used by major players.ThisSomatropinreports main goal is to look at the open doors, threats, and market drivers.A thorough examination of theSomatropinimprovement scenario, venture viability, and key sections is carried out.Calculate the globalSomatropinsegment of the total industry in terms of major segments, locations, and organisations.

Get Access of Our Latest Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/4062

Regions Covered in theSomatropinMarket:

1. South AmericaSomatropinMarket Covers Colombia, Brazil, and Argentina.2. North AmericaSomatropinMarket Covers Canada, United States, and Mexico.3. EuropeSomatropinMarket Covers UK, France, Italy, Germany, and Russia.4. The Middle East and AfricaSomatropinMarket Covers UAE, Saudi Arabia, Egypt, Nigeria, and South Africa.5. Asia PacificSomatropinMarket Covers Korea, Japan, China, Southeast Asia, and India.

Detailed Segmentation:

By Dosage Form:

By Application:

Aim of the study:

-Market size by primary regions/nations, as well as other segments included in the study, are considered and analyzed.-Better understanding of the market structure.-Focuses on Market Players to define, portray, and investigate the value, share, market rivalry scene, SWOT analysis, and future development plans.-To look into the markets distinctive development patterns, future prospects, and overall commitment.-To communicate detailed information about the key factors influencing market growth (growth potential, industry-explicit difficulties, and dangers).-To evaluate the market size in comparison to key regions (along with their respective key countries).-To examine market developments such as market expansions, collaborations, new product launches, and acquisitions for competition analysis.-To provide a strategic profile of the important players, as well as a comprehensive analysis of their growth strategies.

Some Major TOC Points:

:SomatropinMarket Overview, Product Overview, Market Segmentation, Market Overview of Regions, Market Dynamics, Limitations, Opportunities and Industry News and Policies. :SomatropinIndustry Chain Analysis, Upstream Raw Material Suppliers, Major Players, Production Process Analysis, Cost Analysis, Market Channels, and Major Downstream Buyers. : Value Analysis, Production, Growth Rate and Price Analysis by Type ofSomatropin. : Downstream Characteristics, Consumption and Market Share by Application ofSomatropin. : Production Volume, Price, Gross Margin, and Revenue ($) ofSomatropinby Regions. :SomatropinProduction, Consumption, Export, and Import by Regions. :SomatropinMarket Status and SWOT Analysis by Regions. : Competitive Landscape, Product Introduction, Company Profiles, Market Distribution Status by Players ofSomatropin. :SomatropinMarket Analysis and Forecast by Type and Application. :SomatropinMarket Analysis and Forecast by Regions. :SomatropinIndustry Characteristics, Key Factors, New Entrants SWOT Analysis, Investment Feasibility Analysis. :SomatropinMarket Conclusion of the Whole Report.Continued

Finally, the report majorly enlightens the key growth and limiting factors which majorly targets at the center of the market affecting the growth and its development in either positive or negative extent. The report also specifies the impact of regulations and policies implemented by the administration over the current growth and upcoming opportunities that may lead to the market development escalation. TheSomatropinMarket report offers a superior vision of the global market, which will help clients to manage the business precisely with better growth and expansion compared to its contenders in the market.

Buy This Complete Business Report @https://www.coherentmarketinsights.com/insight/buy-now/4062

About us:

Coherent Market Insights is a global market intelligence and consulting firm that offers syndicated and customised research reports as well as consulting services. Were known for our actionable insights and reliable reports in a wide range of industries, including aerospace and defence, agriculture, food and beverage, automotive, chemicals and materials, and virtually every other domain and sub-domain imaginable. Our clients benefit from our highly reliable and accurate reports. Were also committed to continuing to provide measurable, long-term results for our clients after COVID-19 by playing a leading role in providing insights into various sectors.

Contact us:

Mr. ShahUS +12067016702 / UK +4402081334027Email: [emailprotected]

See the original post:

Somatropin Market Increasing focused on developing advanced of growth hormone deficiency is expected to boost the growth of the market - Digital...

Biosimilars Market Growth Rate And Competition Landscape, Forecast From 2022 To 2030 This Is Ardee – This Is Ardee

Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Any differences are carefully evaluated by manufacturers and reviewed by the FDA to ensure the biosimilar meets the Agencys appropriately high approval standards.According to market research study published by Report Ocean, the global biosimilars market is expected to reach approximately USD 71,843 million, representing a CAGR of 28.9% during the forecast period 2022-2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global biosimilars market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the biosimilars industry.

Download Free Sample of This Strategic Report:https://reportocean.com/industry-verticals/sample-request?report_id=gc1089

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, application, and region. The global market for biosimilars can be segmented by type: fusion protein, monoclonal antibodies, recombinant growth factors, recombinant hormones, others. Among these, the monoclonal antibodies segment was accounted for the highest revenue generator in 2021. Biosimilars market is further segmented by application: autoimmune and inflammatory, blood disorders, diabetes, growth hormone deficiency, infectious diseases, oncology, others. The oncology segment is estimated to account for the largest share of the global biosimilars market. Based on region, the biosimilars market is segmented into: Asia Pacific, Europe, North America, Rest of the World (RoW). Europe held the largest share of the global biosimilars market in 2021 and is anticipated to hold its share during the forecast period.

By type:

fusion proteinmonoclonal antibodiesrecombinant growth factorsrecombinant hormonesothers

By application:autoimmune and inflammatoryblood disordersdiabetesgrowth hormone deficiencyinfectious diseasesoncologyothers

By region:Asia PacificEuropeNorth AmericaRest of the World (RoW)

The market research report covers the analysis of key stake holders of the global biosimilars market. Some of the leading players profiled in the report include3SBio Inc., ALVOTECH ehf., Amgen Inc., Biocad CJSC, Biocon Limited, Bio-Thera Solutions, Ltd.,, Boehringer Ingelheim Pharmaceuticals, Inc., Celltrion, Inc., Chong Kun Dang pharmaceutical Corp, CinnaGen Co., Coherus BioSciences, Inc., Dr. Reddys Laboratories Limited, Fresenius Kabi AG, Fujifilm Kyowa Kirin Biologics Co., Ltd., Innovent Biologics, Inc., LG Chem Ltd., Mylan N.V., Nanjing Shunxin Pharmaceuticals Co., Ltd., Outlook Therapeutics, Inc., Pfizer Inc., Reliance Life Sciences, Samsungbioepis Co., Ltd., Sandoz International GmbH, Shanghai Henlius Biotech, Inc., Suzhou Union Biopharm Co., Ltd., Teva Pharmaceutical Industries Ltd., Zydus Lifesciences Limited,among others.

SPECIAL OFFER (Avail an Up-to 30% discount on this report-https://reportocean.com/industry-verticals/sample-request?report_id=gc1089

Scope of the ReportTo analyze and forecast the market size of the global surgical suture market.To classify and forecast the global surgical suture market based on product type, application, region.To identify drivers and challenges for the global surgical suture market.To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global surgical suture market.To identify and analyze the profile of leading players operating in the global surgical suture market.

Why Choose This ReportGain a reliable outlook of the global surgical suture market forecasts from 2022 to 2028 across scenarios.Identify growth segments for investment.Stay ahead of competitors through company profiles and market data.The market estimate for ease of analysis across scenarios in Excel format.Strategy consulting and research support for three months.Print authentication provided for the single-user license.

Table of Content:

Key Questions Answered in the Market Report

Request full Report-https://reportocean.com/industry-verticals/sample-request?report_id=gc1089

About Report Ocean:We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in todays competitive environment. Report Ocean is a one-stop solution for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:Report Ocean:Email:sales@reportocean.comAddress: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 UNITED STATESTel:+1 888 212 3539 (US TOLL FREE)Website:https://www.reportocean.com

See the original post:

Biosimilars Market Growth Rate And Competition Landscape, Forecast From 2022 To 2030 This Is Ardee - This Is Ardee